MN

Mobile-health Network Solutions

MNDRHealthcareNASDAQ

Health Information Services

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$14.0M
+77.4% YoY
Net Income
-$15.6M
-385.6% YoY
EBITDA
-$15.6M
-391.3% YoY

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ MACD Negative CrossoverHistogram -0.0315, negative momentum
Oct 19▼ MACD Negative CrossoverHistogram -0.0157, negative momentum
About Mobile-health Network Solutions

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions primarily in Singapore. With a market capitalization of $1.0M, it sits in micro-cap territory. The company operates in two segments: Telemedicine and Other Services and Sale of Medicine and Medical Devices.

Where MNDR stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, MNDR finished 72.43% below its 150-day moving average ($3.41) and 76.85% below its 200-day moving average ($4.06). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is MNDR overbought or oversold?

At the October 20, 2026 close, MNDR's RSI(14) was 47.2, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.0M
EPS$-14.88
Beta-0.81
52W Change-95.1%
Dividend Yield0.00%
ROE-47.6%
Analysis

The balance sheet looks solid with $3.5M in cash comfortably exceeding the $115K debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Return on equity stands at -47.6%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $2.6M (2021) to $14.0M (2024), reflecting a 441% increase over the period.

MNDR's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. With cash comfortably exceeding debt, MNDR has financial flexibility that may help navigate uncertain periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Mobile-health Network Solutions's trajectory.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms